Institutional Biosafety Committee (IBC)

The IBC is responsible for monitoring and ensuring compliance as well as review and approval of all research projects that involve recombinant DNA materials. CMU is actively committed to preserving the health and safety of its students, staff, and faculty, and to protecting the environment and the community.  It is recognized that use of potentially pathogenic microorganisms and organisms containing recombinant DNA is necessary in many CMU research and teaching laboratories.  To ensure the safe handling of these organisms, Carnegie Mellon University (CMU) requires that all research involving rDNA or hazardous biological materials or toxins conducted at CMU shall be conducted in accordance with federal and state laws.

Forms, Training and rDNA information

Contact Andrew Lawson (412-268-8405) for information on submitting a protocol and training.  E-mail Andrew at alawson@andrew.cmu.edu

 Biosafety Links

• Office of Biotechnology Activities (OBA) - OBA_link
• NIH Guidelines for Recombinant DNA - NIH rDNA Link
• NIH Biological Decontamination - NIH link
• Risk Group and Biosafety Level Containment Chart - BSL_Charg pdf
• Code of Federal Regulations - CFR Link
• Center for Biologics Evaluation and Research (CBER) - CBER Link
• American Biological Safety Association - ABSA link